Serious discordance between MTBC trace positivity by Xpert MTB/RIF ultra and follow up culture
DOI:
https://doi.org/10.18203/2320-6012.ijrms20203482Keywords:
CBNAAT, GeneXpert, Trace, Ultra, Xpert MTB/RIFAbstract
Authors wish to report a major discordance between Xpert MTB/RIF Ultra Trace positivity (GeneXpert, Cepheid) and follow up by liquid culture.
References
World Health Organization. Policy update: Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children. 2013.
World Health Organization. Rapid Implementation of the Xpert MTB/RIF diagnostic test. Available at: http://www.stoptb.org/wg/gli/assets/documents/. Accessed 28 January 2020.
New Laboratory Diagnostic Tools for Tuberculosis Control. WHO; 2008. Available at: http://www.stoptb. org/assets/ documents/global/ retooling/Diagnostic_Brochure_Print_2009 _Jan_29.pdf. Accessed 28 January 2020.
Opota O, Zakham F, Mazza-Stalder J, Nicod L, Greub G, Jaton K. Added Value of Xpert MTB/RIF Ultra for Diagnosis of Pulmonary Tuberculosis in a Low-Prevalence Setting. J Clin Microbiol, 2019:57(2);e01717-8.
Kendall EA, Schumacher SG, Denkinger CM, Dowdy DW. Estimated clinical impact of the Xpert MTB/RIF Ultra cartridge for diagnosis of pulmonary tuberculosis: A modeling study. PLoS Med. 2017;14(12):e1002472.